Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants

Journal of Psychiatric Research

Volumn 41, Issue 7, 2007, Pages 600-605

  Laske, Christoph ^a   Stransky, Elke ^a   Eschweiler, Gerhard W ^a,b   Klein, Reinhild ^b   Wittorf, Andreas ^a   Leyhe, Thomas ^a,b   Richartz, Elke ^a   Köhler, Niklas ^a   Bartels, Matthias ^a   Buchkremer, Gerhard ^a   Schott, Klaus ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Brain derived neurotrophic factor (BDNF); Controls; Fibromyalgia (FM); Pain

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DOXEPIN; FLUOXETINE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; FIBROMYALGIA; HUMAN; MALE; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL;

AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXEPIN; FEMALE; FIBROMYALGIA; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; NEURONAL PLASTICITY; NOCICEPTORS; PAIN THRESHOLD; REFERENCE VALUES; SPINAL CORD;

EID: 33847254818     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.02.007     Document Type: Article

References (43)

1. Allen A.L., and McCarson K.E. Estrogen increases nociception-evoked brain-derived neurotrophic factor gene expression in the female rat. Neuroendocrinology 81 3 (2005) 193-199
2. Angelucci F., Mathe A.A., and Aloe L. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res 146 (2004) 151-165
3. Aydemir O., Deveci A., and Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29 2 (2005) 261-265
4. Biewer W., Conrad I., and Hauser W. Fibromyalgia. Schmerz 18 2 (2004) 118-124
5. Braun A., Lommatzsch M., Mannsfeldt A., and Neuhaus-Steinmetz U. Cellular source of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation. Am J Respir Cell Mol Biol 21 (1992) 537-546
6. Donovan M.J., Miranda R.C., Kraemer R., McCaffrey T.A., Tessarollo L., and Mahadeo D. Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 147 (1995) 309-324
7. Duric V., and McCarson K.E. Hippocampal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models of pain and stress. Neuroscience 133 4 (2005) 999-1006
8. Epstein S.A., Kay G., Clauw D., Heaton R., Klein D., Krupp L., et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 40 1 (1999) 57-63
9. Fries E., Hesse J., Hellhammer J., and Hellhammer D.H. A new view on hypocortisolism. Psychoneuroendocrinology 30 10 (2005) 1010-1016
10. Fujimura H., Altar C.A., Chen R., Nakamura T., Nakahashi T., Kambayashi J., et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 87 4 (2002) 728-734
11. Garcia R. Stress, metaplasticity, and antidepressants. Curr Mol Med 2 7 (2002) 629-638
12. Gervasoni N., Aubry J.M., Bondolfy G., Osiek C., Schwald M., Bertschy G., et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51 4 (2005) 234-238
13. Giovengo S.L., Russell I.J., and Larson A.A. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol 26 7 (1999) 1564-1569
14. Gran J.T. The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17 4 (2003) 547-561
15. Karege F., Schwald M., and Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328 3 (2002) 261-264
16. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., and Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109 2 (2002) 143-148
17. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M., and Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57 9 (2005) 1068-1072
18. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation. J Exp Med 189 5 (1999) 865-870
19. Laske C, Eschweiler GW. Brain-derived neurotrophic factor (BDNF): From nerve growth factor to modulator of brain plasticity in cognitive processes and psychiatric diseases. Nervenarzt, in press.
20. Lever I., Cunningham J., Grist J., Yip P.K., and Malcangio M. Release of BDNF and GABA in the dorsal horn of neuropathic rats. Eur J Neurosci 18 5 (2003) 1169-1174
21. Lommatzsch M., Schloetcke K., Klotz J., Schuhbaeck K., Zingler D., Zingler C., et al. Brain-derived neurotrophic factor in platelets and airflow limitation in asthma. Am J Respir Crit Care Med 171 2 (2005) 115-120
22. Lommatzsch M., Zingler D., Schuhbaeck K., Schloetcke K., Zingler C., Schuff W.P., et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26 1 (2005) 115-123
23. Malcangio M., and Lessmann V. A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors. Trends Pharmacol Sci 24 (2003) 116-121
24. Mattson M.P., Maudsley S., and Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 27 (2004) 589-594
25. McBeth J., and Silman A.J. The role of psychiatric disorders in fibromyalgia. Curr Rheumatol Rep 3 2 (2001) 157-164
26. Nakahashi T., Fujimura H., Altar C.A., Li J., Kambayashi J., Tandon N.N., et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470 (2000) 113-117
27. Ohayon M.M., and Schatzberg A.F. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry 60 1 (2003) 39-47
28. Pan W., Banks W.A., Fasold M.B., Bluth J., and Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37 12 (1998) 1553-1561
29. Pliego R.F., Bayatti N., Giannakoulopoulos X., Glover V., Bradford H.F., Stern G., et al. Brain-derived neurotrophic factor in human platelets. Biochem Pharmacol 54 (1997) 207-209
30. Poduslo J.F., and Curran G.L. Permeability at the blood-brain barrier and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Mol Brain Res 36 (1996) 280-286
31. Radka S.F., Holst P.A., Fritsche M., and Altar C.A. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 709 (1996) 122-301
32. Ringkamp M., Schmelz M., Kress M., Allwang M., Ogilvie A., and Reeh P.W. Activated human platelets in plasma excite nociceptors in rat skin, in vitro. Neurosci Lett 170 1 (1994) 103-106
33. Rosenfeld R.D., Zeni L., Haniu M., Talvenheimo J., Radka S.F., Bennett L., et al. Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expr Purif 6 (1995) 465-471
34. Schulte-Herbruggen O., Nassenstein C., Lommatzsch M., Quarcoo D., Renz H., and Braun A. Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol 160 1-2 (2005) 204-209
35. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54 1 (2003) 70-75
36. Siuciak J.A., Altar C.A., Wiegand S.J., and Lindsay R.M. Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Res 633 1-2 (1994) 326-330
37. Wallace D.J., Linker-Israeli M., Hallegua D., Silverman S., Silver D., and Weisman M.H. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 40 7 (2001) 743-749
38. Wolfe F., Smythe H.A., Yunus M.B., Benett R.M., and Bombardier C. The American College of Rheumatology: 1990 Criteria for the classification of fibromyalgia syndrome: report of the multicenter criteria committee. Arthritis & Rheumatism 33 (1990) 160-172
39. Xu H.W., Li X.C., Li H.D., Ruan H.Z., and Liu Z.Z. Effects of corticotrophin on pain behaviour and BDNF, CRF levels in frontal cortex of rats suffering from chronic pain. Acta Pharmacol Sin 21 7 (2000) 600-604
40. Yajima Y., Narita M., Usui A., Kaneko C., Miyatake M., Narita M., et al. Direct evidence for the involvement of brain-derived neurotrophic factor in the development of a neuropathic pain-like state in mice. J Neurochem 93 3 (2005) 584-594
41. Yamamoto H., and Gurney M.E. Human platelets contain brain-derived neurotrophic factor. J Neurosci 10 (1990) 3469-3478
42. Zeller J.A., Lindner V., Frahm K., Baron R., and Deuschl G. Platelet activation and platelet-leucocyte interaction in patients with migraine. Subtype differences and influence of triptans. Cephalgia 25 7 (2005) 536-541
43. Zhu Z.W., Friess H., Wang L., Zimmermann A., and Buchler M.W. Brain-derived neurotrophic factor is upregulated and associated with pain in chronic pancreatitis. Dig Dis Sci 46 8 (2001) 1633-1639